Balanced Rock Investment Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$332K Sell
3,827
-51
-1% -$4.89K 0.23% 76
2025
Q4
$373K Sell
3,878
-270
-7% -$26.2K 0.26% 72
2025
Q3
$395K Sell
4,148
-246
-6% -$22.6K 0.29% 70
2025
Q2
$383K Sell
4,394
-48
-1% -$4.07K 0.3% 70
2025
Q1
$399K Sell
4,442
-144
-3% -$12.9K 0.32% 61
2024
Q4
$366K Sell
4,586
-623
-12% -$53.9K 0.29% 64
2024
Q3
$469K Sell
5,209
-44
-0.8% -$3.7K 0.37% 54
2024
Q2
$413K Sell
5,253
-121
-2% -$9.92K 0.35% 60
2024
Q1
$468K Sell
5,374
-665
-11% -$56.8K 0.4% 54
2023
Q4
$497K Buy
+6,039
New +$460K 0.44% 58

Other funds holding MDT

Balanced Rock Investment Advisors's MDT Position: Q1 2026 in Review

Balanced Rock Investment Advisors reduced its Medtronic (MDT) stake by 1.3% in Q1 2026, selling an estimated $4.89K and leaving 3,827 shares worth $332K. The position accounts for 0.23% of the portfolio, ranked #76.

Balanced Rock Investment Advisors first reported a position in MDT in Q4 2023 and has held it in 10 quarters since. The position peaked at $497K in Q4 2023. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Balanced Rock Investment Advisors held 3,827 shares of Medtronic worth $332K as of Q1 2026.
  • Balanced Rock Investment Advisors sold 51 Medtronic shares in Q1 2026, an estimated $4.89K.
  • Medtronic made up 0.23% of Balanced Rock Investment Advisors's portfolio in Q1 2026, its #76 holding.
  • Balanced Rock Investment Advisors first reported a position in Medtronic in Q4 2023 and has held it in 10 quarters since.
  • Balanced Rock Investment Advisors's Medtronic position peaked at $497K in Q4 2023.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Balanced Rock Investment Advisors's 13F filing for Q1 2026, filed 13 May 2026.